Abstract

Two independent mol-ecules comprise the asymmetric unit in the title benzoxatellurole compound, C12H17ClOTe. The mol-ecules, with the same chirality at the methine C atom, are connected into a loosely associated dimer by Te⋯O inter-actions, leading to a {⋯Te-O}2 core. The resultant C2ClO2 donor set approximates a square pyramid with the lone pair of electrons projected to occupy a position trans to the n-butyl substituent. Inter-estingly, the TeIV atoms exhibit opposite chirality. The major difference between the independent mol-ecules relates to the conformation of the five-membered chelate rings, which is an envelope with the O atom being the flap, in one mol-ecule and is twisted about the O-C(methine) bond in the other. No directional inter-molecular inter-actions are noted in the mol-ecular packing beyond the aforementioned Te⋯O secondary bonding. The analysis of the Hirshfeld surface reveals the dominance of H⋯H contacts, i.e. contributing about 70% to the overall surface, and clearly differentiates the immediate crystalline environments of the two independent mol-ecules in terms of both H⋯H and H⋯Cl/Cl⋯H contacts.

Highlights

  • Two independent molecules comprise the asymmetric unit in the title benzoxatellurole compound, C12H17ClOTe

  • The resultant C2ClO2 donor set approximates a square pyramid with the lone pair of electrons projected to occupy a position trans to the n-butyl substituent

  • The major difference between the independent molecules relates to the conformation of the five-membered chelate rings, which is an envelope with the O atom being the flap, in one molecule and is twisted about the O—C(methine) bond in the other

Read more

Summary

Chemical context

Tellurium is not the first element that comes to mind when considering the modern pharmacopoeia (Tiekink, 2012). Investigations into pharmaceutical applications of compounds of this generally regarded as relatively non-toxic element (Nogueira et al, 2004) date back to the times of Sir Alexander Fleming who tested the efficacy of potassium tellurite, K2[TeO3], against microbes, such as penicillin-insensitive bacteria (Fleming, 1932). It is another salt, ammonium trichloro(dioxyethylene-O,O0)tellurate, [NH4][(OCH2CH2O)TeCl3] (Albeck et al, 1998), known as AS-101, that has attracted the most attention as a potential tellurium-based pharmaceutical, being in clinical trials for the treatment of psoriasis (Halpert & Sredni, 2014). A preliminary inhibition assay on (I) against cathepsin B has been performed

Structural commentary
Hirshfeld surface analysis
Supramolecular features
Database survey
Findings
Synthesis and crystallization
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.